Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001392219 | SCV001593860 | likely benign | Neurofibromatosis, type 1 | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004557588 | SCV005048636 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2024-01-30 | criteria provided, single submitter | clinical testing | The c.6462C>T variant (also known as p.V2154V), located in coding exon 42 of the NF1 gene, results from a C to T substitution at nucleotide position 6462. This nucleotide substitution does not change the valine at codon 2154. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |